Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM) [Yahoo! Finance]
Sunshine Biopharma Inc. (SBFM)
NASDAQ:AMEX Investor Relations:
sunshinebiopharma.com/press-releases.html
Company Research
Source: Yahoo! Finance
On paper, it's small, barely a rounding error next to the giants of biotech. But size isn't the story here. Execution is. Sunshine has spent the past year building an engine that's starting to hum across multiple fronts: generics, biosimilars, mRNA cancer therapies, and antiviral research. And in the process, it's doing what small companies rarely do well: scale with discipline In Canada, Sunshine's Nora Pharma subsidiary has been quietly expanding its generics portfolio, stacking products that feed real, repeatable revenue. The launch of gabapentin , a generic version of Neurontin used for nerve pain, wasn't just another SKU- it marked SBFM's ability to execute on commercial distribution and regulatory follow-through. Each new product gives Nora a stronger foothold in Canada's growing generic pharmaceutical market, a region known for its efficiency, stability, and high barrier to entry. It also shows that Sunshine isn't building flash; it's building foundations. And once those fo
Show less
Read more
Impact Snapshot
Event Time:
SBFM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SBFM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SBFM alerts
High impacting Sunshine Biopharma Inc. news events
Weekly update
A roundup of the hottest topics
SBFM
News
- Sunshine Biopharma approves $5M strategic bitcoin investment [Seeking Alpha]Seeking Alpha
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections [Yahoo! Finance]Yahoo! Finance
- Sunshine Biopharma (NASDAQ:SBFM) had its "buy" rating reaffirmed by analysts at Aegis. They now have a $7.00 price target on the stock.MarketBeat
- Sunshine Biopharma (NASDAQ:SBFM) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
SBFM
Sec Filings
- 10/23/25 - Form DEFA14A
- 10/23/25 - Form DEF
- 9/30/25 - Form 8-K
- SBFM's page on the SEC website